Egetis Therapeutics AB (P0F.STU) Q2 2026 Earnings

29AprConfirmed
Q2 2026
-0.02
-0.02
-0.02
-0.02

Details

Expected EPS
-0.01711532464
Actual EPS
-0.02161935744
Surprise EPS
-0
Surprise Percent
+26.32%

Description

Egetis Therapeutics AB (P0F.STU) has reported earnings of -0.02161935744 per share for Q2 2026.

0 Comments

Share your thoughts